Compact Human Fgfr4 Active Recombinant Protein C-his Tag Lyophilized Series [2G6nhkUQ]
Human FGFR4 Recombinant Protein C-His Tag Lyophilized from Innovative Research has been recombinantly produced in HEK293 Cells. The protein formulation is lyophilized from sterile PBS, pH 7.4 with a purity of > 97 % as determined by reducing SDS-P
Secure Shopping
100% Safe Guarantee
Free Shipping
On orders over $30
Money-Back
30-Day Guarantee
Human FGFR4 Recombinant Protein C-His Tag Lyophilized from Innovative Research has been recombinantly produced in HEK293 Cells. The protein formulation is lyophilized from sterile PBS, pH 7.4 with a purity of > 97 % as determined by reducing SDS-PAGE..
More Details:
- Species: Human
- Target: FGFR4
- Purity: > 97 % as determined by reducing SDS-PAGE..< 1.0 EU per ug as determined by the LAL method.
- Source: HEK293 Cells
- Storage Conditions: Lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8? for 2-7 days. Aliquots of reconstituted samples are stable at < -20? for 3 months.
Fibroblast growth factor receptor 4 (FGFR4) also known as CD334 antigen or tyrosine kinase related to fibroblast growth factor receptor, is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of FGFR4/CD334 interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. FGFR4/CD334 preferentially binds acidic fibroblast growth factor and, although its specific function is unknown, it is overexpressed in gynecological tumor samples, suggesting a role in breast and ovarian tumorigenesis. FGFR4/CD334 signaling is down-regulated by receptor internalization and degradation; MMP14 promotes internalization and degradation of FGFR4/CD334. Mutations in FGFR4/CD334 lead to constitutive kinase activation or impair normal FGFR4 inactivation lead to aberrant signaling.Immune Checkpoint Immunotherapy Cancer Immunotherapy Targeted Therapy
At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.
For research use only.
What Our Customers Say
Absolutely no complaints!
This product is a superb performer. It's a great addition to my collection.
- Colin C..
Absolutely no complaints!
The design is minimalist and the performance is maximalist.
- Arden V..
Absolutely no complaints!
This is a product that has clearly been tested rigorously.
- Daleyza O..